Welcome to our newest team members, Tahir Juba and Derek Edwards!
The PATIENTS Program Receives $2 Million NIA Award!
Attend PATIENTS Day 2022!

C. Daniel Mullins, PhD, is a professor in the Department of Pharmaceutical Health Services Research (PHSR) at the University of Maryland School of Pharmacy.

Professor Mullins’ research and teaching focus on community-engaged, patient-centered comparative effectiveness research to advance health equity. He has received funding as Principal Investigator from the Agency for Healthcare Research and Quality (AHRQ), the Food and Drug Administration (through its CERSI initiative), National Institute on Aging (NIA), the Patient-Centered Outcomes Research Institute (PCORI), various pharmaceutical manufacturers including Bayer, Merck, and Pfizer, patient advocacy organizations, and the insurance industry. For more information on Professor Mullins’ research projects, please see the Research Projects section.

In addition to his faculty appointment, Professor Mullins also serves as Executive Director of The PATIENTS Program at the School of Pharmacy and Director of the Community & Collaboration Core for the UMB Institute for Clinical and Translational Research, as well as Editor-in-Chief for Value in Health.